Logo image of EKOP.BR

EKOPAK NV (EKOP.BR) Stock Fundamental Analysis

EBR:EKOP - Euronext Brussels - BE0974380124 - Common Stock - Currency: EUR

12.2  +0.2 (+1.67%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to EKOP. EKOP was compared to 44 industry peers in the Commercial Services & Supplies industry. EKOP may be in some trouble as it scores bad on both profitability and health. EKOP is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

EKOP had negative earnings in the past year.
EKOP had a positive operating cash flow in the past year.
EKOP had negative earnings in 4 of the past 5 years.
In multiple years EKOP reported negative operating cash flow during the last 5 years.
EKOP.BR Yearly Net Income VS EBIT VS OCF VS FCFEKOP.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -5M -10M

1.2 Ratios

EKOP's Return On Assets of -3.20% is on the low side compared to the rest of the industry. EKOP is outperformed by 67.39% of its industry peers.
EKOP's Return On Equity of -9.12% is on the low side compared to the rest of the industry. EKOP is outperformed by 60.87% of its industry peers.
Industry RankSector Rank
ROA -3.2%
ROE -9.12%
ROIC N/A
ROA(3y)-1.96%
ROA(5y)-0.86%
ROE(3y)-3.48%
ROE(5y)-1.29%
ROIC(3y)N/A
ROIC(5y)N/A
EKOP.BR Yearly ROA, ROE, ROICEKOP.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 50 100 150 200 250

1.3 Margins

EKOP has a Gross Margin of 31.40%. This is comparable to the rest of the industry: EKOP outperforms 41.30% of its industry peers.
In the last couple of years the Gross Margin of EKOP has declined.
The Profit Margin and Operating Margin are not available for EKOP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.58%
GM growth 5Y-5.29%
EKOP.BR Yearly Profit, Operating, Gross MarginsEKOP.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 10 -10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

EKOP does not have a ROIC to compare to the WACC, probably because it is not profitable.
EKOP has about the same amout of shares outstanding than it did 1 year ago.
EKOP has more shares outstanding than it did 5 years ago.
EKOP has a worse debt/assets ratio than last year.
EKOP.BR Yearly Shares OutstandingEKOP.BR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 5M 10M
EKOP.BR Yearly Total Debt VS Total AssetsEKOP.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of 1.36, we must say that EKOP is in the distress zone and has some risk of bankruptcy.
EKOP's Altman-Z score of 1.36 is in line compared to the rest of the industry. EKOP outperforms 45.65% of its industry peers.
EKOP has a Debt/Equity ratio of 0.95. This is a neutral value indicating EKOP is somewhat dependend on debt financing.
EKOP's Debt to Equity ratio of 0.95 is in line compared to the rest of the industry. EKOP outperforms 45.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF N/A
Altman-Z 1.36
ROIC/WACCN/A
WACC6.93%
EKOP.BR Yearly LT Debt VS Equity VS FCFEKOP.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

A Current Ratio of 1.18 indicates that EKOP should not have too much problems paying its short term obligations.
EKOP's Current ratio of 1.18 is in line compared to the rest of the industry. EKOP outperforms 50.00% of its industry peers.
A Quick Ratio of 0.96 indicates that EKOP may have some problems paying its short term obligations.
EKOP has a Quick ratio (0.96) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 0.96
EKOP.BR Yearly Current Assets VS Current LiabilitesEKOP.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

7

3. Growth

3.1 Past

The earnings per share for EKOP have decreased strongly by -310.53% in the last year.
Looking at the last year, EKOP shows a very strong growth in Revenue. The Revenue has grown by 121.96%.
EKOP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.37% yearly.
EPS 1Y (TTM)-310.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-828.57%
Revenue 1Y (TTM)121.96%
Revenue growth 3Y56.07%
Revenue growth 5Y40.37%
Sales Q2Q%128.57%

3.2 Future

The Earnings Per Share is expected to grow by 75.07% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 30.77% on average over the next years. This is a very strong growth
EPS Next Y-206.25%
EPS Next 2Y60.73%
EPS Next 3Y82.34%
EPS Next 5Y75.07%
Revenue Next Year49.82%
Revenue Next 2Y48.17%
Revenue Next 3Y37.05%
Revenue Next 5Y30.77%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
EKOP.BR Yearly Revenue VS EstimatesEKOP.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
EKOP.BR Yearly EPS VS EstimatesEKOP.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EKOP. In the last year negative earnings were reported.
EKOP is valuated quite expensively with a Price/Forward Earnings ratio of 256.28.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EKOP indicates a slightly more expensive valuation: EKOP is more expensive than 60.87% of the companies listed in the same industry.
EKOP is valuated expensively when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 256.28
EKOP.BR Price Earnings VS Forward Price EarningsEKOP.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200 250

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EKOP is valued a bit more expensive than the industry average as 63.04% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 60.57
EKOP.BR Per share dataEKOP.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

EKOP's earnings are expected to grow with 82.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.73%
EPS Next 3Y82.34%

More info and screens

0

5. Dividend

5.1 Amount

EKOP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EKOPAK NV

EBR:EKOP (3/7/2025, 7:00:00 PM)

12.2

+0.2 (+1.67%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.02%
Inst Owner ChangeN/A
Ins Owners79.19%
Ins Owner ChangeN/A
Market Cap180.80M
Analysts82.22
Price Target18.36 (50.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-23.4%
PT rev (3m)-25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-133.33%
EPS NY rev (3m)-83.75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-12.47%
Revenue NY rev (3m)-21.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 256.28
P/S 3.33
P/FCF N/A
P/OCF 85.57
P/B 3.49
P/tB 341.78
EV/EBITDA 60.57
EPS(TTM)-0.32
EYN/A
EPS(NY)0.05
Fwd EY0.39%
FCF(TTM)-1.95
FCFYN/A
OCF(TTM)0.14
OCFY1.17%
SpS3.67
BVpS3.5
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.2%
ROE -9.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.4%
FCFM N/A
ROA(3y)-1.96%
ROA(5y)-0.86%
ROE(3y)-3.48%
ROE(5y)-1.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.58%
GM growth 5Y-5.29%
F-Score3
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF N/A
Debt/EBITDA 12.77
Cap/Depr 364.09%
Cap/Sales 57.04%
Interest Coverage N/A
Cash Conversion 54.83%
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 0.96
Altman-Z 1.36
F-Score3
WACC6.93%
ROIC/WACCN/A
Cap/Depr(3y)612.46%
Cap/Depr(5y)506.59%
Cap/Sales(3y)62.12%
Cap/Sales(5y)44.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-310.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-828.57%
EPS Next Y-206.25%
EPS Next 2Y60.73%
EPS Next 3Y82.34%
EPS Next 5Y75.07%
Revenue 1Y (TTM)121.96%
Revenue growth 3Y56.07%
Revenue growth 5Y40.37%
Sales Q2Q%128.57%
Revenue Next Year49.82%
Revenue Next 2Y48.17%
Revenue Next 3Y37.05%
Revenue Next 5Y30.77%
EBIT growth 1Y-231.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1377.78%
EBIT Next 3Y247.6%
EBIT Next 5Y134.81%
FCF growth 1Y-123.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y143.32%
OCF growth 3YN/A
OCF growth 5Y88.75%